Pharming Group to report third quarter 2023 financial results on October 26
2023年10月12日 - 3:00PM
Leiden, The Netherlands, October 12,
2023: Pharming Group N.V. (“Pharming”) (Euronext
Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its
preliminary (unaudited) third quarter 2023 financial results, for
the period ended September 30, on Thursday, October 26, 2023.
Pharming will host a presentation for analysts
and investors at 13:30 CEST/07:30 EDT on October 26, 2023.
To participate in the conference call, please
register in advance using the link below. Once registered, dial-in
information and a unique PIN will be provided, allowing access to
the call.
Conference call
registration:
Please note, the Company will only take
questions from dial-in attendees.
https://register.vevent.com/register/BIb15561b07c01418199d56096c5c3c8f9
To watch the live webcast, please register in
advance using the link below.
Webcast registration:
https://edge.media-server.com/mmc/p/599pzbd7
About Pharming Group N.V.
Pharming Group N.V. (Euronext Amsterdam:
PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated
to transforming the lives of patients with rare, debilitating, and
life-threatening diseases. Pharming is commercializing and
developing an innovative portfolio of protein replacement therapies
and precision medicines, including small molecules, biologics, and
gene therapies that are in early to late-stage development.
Pharming is headquartered in Leiden, Netherlands, and has employees
around the globe who serve patients in over 30 markets in North
America, Europe, the Middle East, Africa, and Asia-Pacific.
For more information, visit www.pharming.com and
find us on LinkedIn.
For further public information,
contact:
Pharming Group, Leiden, The
NetherlandsMichael Levitan, VP Investor Relations &
Corporate CommunicationsT: +1 (908) 705 1696
Heather Robertson, Investor Relations &
Corporate Communications ManagerE: investor@pharming.com
FTI Consulting, London,
UKVictoria Foster Mitchell/Alex Shaw/Amy ByrneT: +44 203
727 1000
LifeSpring Life Sciences Communication,
Amsterdam, The NetherlandsLeon MelensT: +31 6 53 81 64
27E: pharming@lifespring.nl
Pharming Group NV (EU:PHARM)
過去 株価チャート
から 12 2024 まで 1 2025
Pharming Group NV (EU:PHARM)
過去 株価チャート
から 1 2024 まで 1 2025
